Democratic presidential candidate Bernie Sanders conceded this week that he was not going to be the party’s nominee.
In an C-SPAN interview that aired on Wednesday, Sanders spoke of his role at the upcoming Democratic National Convention.
“It’s hard to say,” he explained. “It doesn’t appear that I’m going to be the nominee so I’m not going to be determining the scope of the convention.”
Sanders called on Democrats to “create the most progressive platform as we possibly can reflecting the needs of working families and students and the environment, health care and so forth.”
The Vermont Senator also predicted that his supporters would not vote for presumptive Republican nominee Donald Trump.
“The vast majority of the people who voted for me understand that Donald Trump in a dozen different ways is literally unfit to be president of the United States,” he explained. “And it’s not only his views on the issues… but mostly his making bigotry the cornerstone of this campaign.”
Watch the video below from C-SPAN.
— CSPAN (@cspan) June 22, 2016
(h/t: The Hill)
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.